LDHA and hepatocellular carcinoma: Through various in vivo and in vitro HCC models, we comprehensively demonstrated that circSMPD4 promotes tumor lactate metabolic reprogramming by inhibiting LDHA degradation through CMA‐lysosome pathway, ultimately inducing NK‐cell‐related immune escape and enhancing HCC malignancy.